Treatment of primary liver tumors with yttrium-90 microspheres (TheraSphere®) in high risk patients: Analysis of survival and toxicities

Technology in Cancer Research and Treatment

Volumn 8, Issue 1, 2009, Pages 71-77

  Reardon, Kelli A ^a   McIntosh, Alyson F ^a   Shilling, A Tanner ^a   Hagspiel, Klaus D ^a   Al Osaimi, Abdullah ^a   Berg, Carl ^a   Caldwell, Stephen H ^a   Northup, Patrick G ^a   Angle, Fritz ^a   Mulder, Robert ^a   Rich, Tyvin A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Hepatocellular carcinoma; Liver cancer; Microspheres; SIR Spheres; Therasphere; Yttrium 90

Indexed keywords

ANTINEOPLASTIC AGENT; MACROSALB TC 99M; MICROSPHERE; YTTRIUM 90;

ABDOMINAL PAIN; ABSCESS; ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DRUG FEVER; DYSPEPSIA; FATIGUE; FEMALE; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; NAUSEA; RADIATION DOSE; RADIOFREQUENCY ABLATION; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 60849114950     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460900800109     Document Type: Article

References (18)

1. Cancer facts & figures 2007. Atlanta, GA, American Cancer Society (2007).
2. Salem, R., Lewandowski, R., Roberts, C., Goin, J., Thurston, K., Abouljoud, M., Courtney, A. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15, 335-345 (2004).
3. Sturm, J. W., Keese, M. Multimodal Treatment of Hepatocellular Carcinoma (HCC). Onkologie 27, 294-303 (2004).
4. Izzo, F., Cremona, F., Ruffolo, F., Palaia, R., Parisi, V., Curley, S. Outcome of 67 Patients With Hepatocellular Cancer Detected During Screening of 1125 Patients With Chronic Hepatitis. Annals of Surgery 227, 513-518 (1998).
5. Salem, R., Hunter, R. D. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review. Int J Radiat Oncol Biol Phys 66(2 Suppl), S83-88 (2006).
6. Kulik, L. M. Advancements in hepatocellular carcinoma. Curr Opin Gastroenterol 23, 268-274 (2007).
7. Vivarelli, M., Bellusci, R., Cucchetti, A., Cavrini, G., De Ruvo, N., Aden, A. A., La Barba, G., Brillanti, S., Cavallari, A. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation 74, 1746-1751 (2002).
8. Marrero, J. A. Hepatocellular carcinoma. Curr Opin Gastroenterol 19, 243-249 (2003).
9. Goin, J. E., Salem, R., Carr, B. I., Dancey, J. E., Soulen, M. C., Geschwind, J. F., Goin, K., Van Buskirk, M., Thurston, K. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 16, 195-203 (2005).
10. Goin, J. E., Salem, R., Carr, B. I., Dancey, J. E., Soulen, M. C., Geschwind, J. F., Goin, K., Van Buskirk, M., Thurston, K. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16, 205-213 (2005).
11. TheraSphere Yttrium-90 microspheres [package insert]. Kanata, ON, Canada, MDS Nordion (2004).
12. Salem, R., Thurston, K. G. Radioembolization with 90Yttrium micro-spheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17, 1251-1278 (2006).
13. Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., Gwyther, S. G. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92, 205-216 (2000).
14. Carr, B. I. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Hepatogastroenterology 4, 79-86 (2002).
15. Stillwagon, G. B., Order, S. E., Guse, C., Klein, J. L., Leichner, P. K., Leibel, S. A., Fishman, E. K. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study. Int J Radiat Oncol Biol Phys 17, 1223-1229 (1989).
16. Dawson, L. A., McGinn, C. J., Lawrence, T. S. Conformal chemo-radiation for primary and metastatic liver malignancies. Semin Surg Oncol 21, 249-255 (2003).
17. Dawson, L. A., McGinn, N. J., Ensminger, W. D. Preliminary results of escalated focal liver radiation and hepatic artery floxuridine for unresectable liver malignancies. Proc Am Soc Clin Oncol 18, 86 (1999).
18. Kennedy, A., Nag, S., Salem, R., Murthy, R., McEwan, A. J., Nutting, C., Benson, A. 3rd, Espat, J., Bilbao, J. I., Sharma, R. A., Thomas, J. P., Coldwell, D. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68, 13-23 (2007).